Researchers find that increasing IRAK-M protein levels in retinal cells could be a new, effective treatment for age-related macular degeneration.
A key protein boost could help protect against age-related vision loss, according to a new study led by the University of Bristol, US, Germany, and Australia. Researchers discovered that increasing the levels of IRAK-M in retinal cells could offer a new and highly effective treatment for age-related macular degeneration (AMD), a leading cause of vision loss among older adults. The breakthrough could potentially pave the way for gene therapies to boost IRAK-M levels and protect against AMD.
June 05, 2024
9 Articles